Literature DB >> 6109955

Co-trimoxazole for systemic leishmaniasis.

K J Murphy, A C Bong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6109955     DOI： 10.1016/s0140-6736(81)91929-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Chemotherapy of leishmaniasis in India.

Authors:  C P Thakur
Journal:  Indian J Pediatr       Date:  1987 Jan-Feb       Impact factor: 1.967

2.  Co-trimoxazole for visceral leishmaniasis.

Authors:  A Rodriguez-Cuartero; F J Pérez-Blanco; A López-Fernández
Journal:  Infection       Date:  1990 Jan-Feb       Impact factor: 3.553

3.  Metronidazole and Indian kala-azar: results of a clinical trial.

Authors:  M Mishra; B D Thakur; M Choudhary
Journal:  Br Med J (Clin Res Ed)       Date:  1985-12-07

4.  In vitro activity of sulfonamides and sulfones against Leishmania major promastigotes.

Authors:  M P Peixoto; S M Beverley
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.